MYB anticorps (AA 506-534)
Aperçu rapide pour MYB anticorps (AA 506-534) (ABIN3029530)
Antigène
Voir toutes MYB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 506-534
-
Purification
- Antigen affinity purified
-
Immunogène
- A portion of amino acids 506-534 from the human protein was used as the immunogen for this Myb antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the Myb antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. IHC (Paraffin): 1:50-1:100,Western blot: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Myb antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- MYB (V-Myb Myeloblastosis Viral Oncogene Homolog (Avian) (MYB))
-
Autre désignation
- Myb
-
Sujet
- Myb is a transcriptional activator, DNA-binding protein that recognizes the sequence 5'-YAAC[GT]G-3'. It participates in the control of proliferation and differentiation of hematopoietic progenitor cells. Myb is a transcription factor related to Myc, and is expressed predominantly in haematopoietic cells and immature gastroepithelial cells. TRAF7 stimulates the sumoylation of Myb at Lys-523 and Lys-499, which are the same sites as those used for PIASy-induced sumoylation. A correlation has been established between reduction in sumoylation of Myb and increase in transcriptional activation. Negative influence on transactivation properties by the negative regulatory domain region of c-Myb depends on upon sumoylation.
-
UniProt
- P10242
-
Pathways
- Chromatin Binding, Positive Regulation of Immune Effector Process
Antigène
-